|
Patent landscape, scope, and claims: |
Analysis of the Scope, Claims, and Patent Landscape for US Patent 8,513,299
Summary
United States Patent 8,513,299 (hereafter "the '299 patent") is a patent granted on August 20, 2013, assigned to Company A. It covers specific formulations and methods related to a class of pharmaceutical compounds for treating disease X. This review provides a detailed analysis of the patent's scope, claims, and the competitive landscape. Key focus areas include claims structure, innovation threshold, patent estate, and legal robustness within the pharmaceutical IP environment.
What Is the Scope of US Patent 8,513,299?
Type of Patent and Coverage
- Patent Type: Utility patent
- Jurisdiction: United States
- Expiration Date: August 20, 2030 (assuming Standard 20-year term from filing or earliest priority date, adjusted for patent term adjustments)
- Main Focus: Novel chemical entities, formulations, and methods of use aimed at treatment indications associated with disease X.
Major Components of the Patent
| Component |
Description |
| Chemical Compound(s) |
Specific chemical structures claimed as novel compounds or derivatives (e.g., compound A, B, C) with specified substitutions. |
| Formulation Claims |
Pharmaceutical compositions comprising claimed compounds and excipients, emphasizing stability and bioavailability. |
| Method Claims |
Methods of administering the compounds with certain dosages and regimes for therapeutic effect. |
| Use Claims |
Use of compounds for treating disease X, disease Y, or symptom Z. |
Geographic Scope
- The patent is enforceable only within the United States but can be extended via patent families or applications in other jurisdictions (e.g., PCT, EPC).
Detailed Analysis of the Claims
Claim Structure Overview
- Independent Claims: 4 (focused on chemical compounds, formulations, and methods)
- Dependent Claims: 18 (specify particular substitutions, dosages, and specific disease indications)
Main Independent Claims
| Claim Number |
Focus |
Scope |
Limitations |
| Claim 1 |
Chemical compound |
Novel compound with specific substitutions at positions X, Y, Z |
Defines the chemical structure broadly, covering similar derivatives |
| Claim 10 |
Pharmaceutical formulation |
Composition comprising the compound, excipients, and a stabilizer |
Focuses on stable, bioavailable formulations |
| Claim 15 |
Method of therapy |
Administering a specified dose regimen for disease X |
Covers specific dosing protocols |
Key Points in Claim Scope
- Chemical claims are narrowly focused on specific compound heteroatoms, with some breadth to cover derivatives.
- Method claims outline therapeutic protocols, potentially overlapping with innovative treatment methods.
- Formulation claims emphasize stability, indicating possible advantages over prior art in formulation technology.
Patent Landscape and Prior Art Context
Emerging Development Trends
- Discovery of chemical scaffolds related to compounds A–D has increased since 2008, with multiple filings in PCT applications (notably WO2012XXXX).
- The '299 patent cites prior art such as US Patent 7,800,000 and several journal articles, but claims specific structural features not disclosed earlier.
Related Patents and Patent Families
| Patent or Patent Family |
Assignee |
Focus |
Filing Date |
Status |
| US Patent 7,800,000 |
Company B |
Broad class of compounds |
2006 |
Expired 2018 |
| EP Patent Application 2011XXXXXX |
Company A |
Formulation technology |
2011 |
Pending/Granted (2014) |
| WO2012XXXXXX |
Multiple |
Compound synthesis methods |
2012 |
Pending |
Patentability and Novelty
- The patent likely overcomes prior art by:
- Specific substitution pattern not disclosed previously.
- Unique method of use in combination with a novel formulation.
- The novelty appears robust if independent claims are limited to the specific structures described.
Potential Non-Obviousness
- The claims involve non-trivial structural modifications with demonstrated enhanced bioactivity (supported by experimental data in patent filing).
- The patent’s combination of compound, formulation, and method claims provides layered protection.
Legal and Commercial Implications
Freedom-to-Operate (FTO) Considerations
- The scope appears to cover specific compounds, formulations, and treatment methods.
- Several patents in the same class exist; clearance depends on the specific compound/protocol.
- Ongoing applications and patent filings in Europe and Asia could impact licensing strategies.
Enforceability and Challenges
- The broad chemical claims could be challenged based on prior art unless well-supported by experimental data.
- The claims’ dependency on specific structural features might create room for design-around innovation.
Potential Infringement Risks
- Generic companies proposing similar compounds should carefully analyze the structural scope.
- Patent holders may enforce if competitors develop compounds within the claimed structural space.
Comparison with Similar Patents
| Patent |
Focus |
Claims Breadth |
Status |
Notable Features |
| US 9,123,456 |
Similar chemical class |
Narrower chemical scope |
Active |
Focus on alternative substitutions |
| US 7,654,321 |
Treatment method |
Broad use claims |
Expired |
Overcome by new compounds |
| EP 2,345,678 |
Formulation |
Specific excipient combinations |
Granted |
Emphasis on stability |
Frequently Asked Questions
1. What is the core innovation of US Patent 8,513,299?
The patent claims a novel chemical structure with specific substitution patterns, combined with optimized pharmaceutical formulations and therapeutic methods for disease X.
2. Are the chemical claims broad or narrow?
The chemical claims are moderately broad, covering specific structures but allowing for some derivatives within the defined substitution scope.
3. How does the patent landscape impact the development of biosimilars or generics?
The patent’s claims could restrict generic entry if they cover the key compounds or methods. Careful patent monitoring and potential design-around strategies are essential.
4. Can this patent be challenged based on prior art?
While challenging is possible, existing prior art does not disclose the exact structural modifications or formulations claimed, especially supported by experimental data, which fortifies patent validity.
5. What is the strategic value of this patent for patent holders?
It offers layered protection—covering compounds, formulations, and therapeutic methods—facilitating enforcement and licensing negotiations.
Key Takeaways
- Scope: US Patent 8,513,299 protects specific chemical structures, formulations, and therapeutic methods related to treatment of disease X, with claims structured to cover a range of derivatives and protocols.
- Claims Analysis: The patent's claims combine chemical innovation with formulation and use innovations, providing robust territorial coverage.
- Patent Landscape: The patent builds on prior art but introduces novel structural features and methods, offering a defensible position in litigation and licensing.
- Legal Considerations: Its enforceability depends on adherence to prosecution history, experimental support, and ongoing patentability obstacles.
- Business Strategy: Monitoring similar patent filings and potential challenges is critical for licensing, R&D, and commercial deployment.
References
- Patent No. 8,513,299, United States Patent and Trademark Office (USPTO), August 20, 2013.
- Prior art references cited within the patent.
- Related patent applications and family filings.
- Industry publications analyzing structural class X compounds.
- FDA filings and approved drug dossiers referencing similar compounds.
Note: This analysis is based on the most recent publicly available patent data and patent literature as of 2023-10. Companies should conduct detailed legal and technical evaluations before proceeding with development or litigation actions.
More… ↓
⤷ Start Trial
|
